127 related articles for article (PubMed ID: 1352811)
1. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
Uekama K; Adachi H; Irie T; Yano T; Saita M; Noda K
J Pharm Pharmacol; 1992 Feb; 44(2):119-21. PubMed ID: 1352811
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101.
Adachi H; Irie T; Uekama K; Manako T; Yano T; Saita M
J Pharm Pharmacol; 1992 Dec; 44(12):1033-5. PubMed ID: 1361553
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of hydroxypropyl-beta-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Eur J Pharm Sci; 1998 Jan; 6(1):53-9. PubMed ID: 16256708
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new penetration enhancer 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101).
Yano T; Higo N; Furukawa K; Tsuji M; Noda K; Otagiri M
J Pharmacobiodyn; 1992 Sep; 15(9):527-33. PubMed ID: 1287186
[TBL] [Abstract][Full Text] [Related]
5. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the percutaneous penetration of prostaglandin E1 and its ethyl ester.
Sheu MT; Lin LH; Spur BW; Wong PY; Chiang HS
J Control Release; 1998 Nov; 55(2-3):153-60. PubMed ID: 9795039
[TBL] [Abstract][Full Text] [Related]
7. The transepidermal absorption of prostaglandin E1 as a topical ointment: an experimental study of application over a rat skin flap.
Nakanishi Y; Nakajima T; Yoshimura Y; Okamoto Y; Yamada T
Ann Plast Surg; 1998 Jan; 40(1):44-7. PubMed ID: 9464695
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben.
Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S
J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982
[TBL] [Abstract][Full Text] [Related]
9. Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy.
Utsuki T; Uchimura N; Irikura M; Moriuchi H; Holloway HW; Yu QS; Spangler EL; Mamczarz J; Ingram DK; Irie T; Greig NH
J Pharmacol Exp Ther; 2007 Apr; 321(1):353-61. PubMed ID: 17255466
[TBL] [Abstract][Full Text] [Related]
10. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone.
Lopez RF; Collett JH; Bentley MV
Int J Pharm; 2000 Apr; 200(1):127-32. PubMed ID: 10845694
[TBL] [Abstract][Full Text] [Related]
11. Liposome encapsulated prostaglandin E1 in erectile dysfunction: correlation between in vitro delivery through foreskin and efficacy in patients.
Foldvari M; Oguejiofor C; Afridi S; Kudel T; Wilson T
Urology; 1998 Nov; 52(5):838-43. PubMed ID: 9801110
[TBL] [Abstract][Full Text] [Related]
12. Specific augmentation of plantar skin blood flow by lipo-PGE1 assessed in tetrodotoxin- and N(G)-nitro-L-arginine-treated rats.
Chino D; Akimaru S; Kataha K; Ishii K; Nakayama K
J Cardiovasc Pharmacol; 2000 Apr; 35(4):630-7. PubMed ID: 10774795
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
Arima H; Adachi H; Irie T; Uekama K; Pitha J
Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
[TBL] [Abstract][Full Text] [Related]
14. In vitro skin penetration and pharmacodynamic evaluation of prostaglandin E1 ethyl ester, a vasoactive prodrug of prostaglandin E1, formulated into alcoholic hydrogels.
Park HS; Yang SW; Choi SU; Choi HG; Yong CS; Choi YW; Lee J
Pharmazie; 2006 Nov; 61(11):933-7. PubMed ID: 17152986
[TBL] [Abstract][Full Text] [Related]
15. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation.
Saeki S; Yamamura K; Matsushita M; Nishikimi N; Sakurai T; Nimura Y
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):525-9. PubMed ID: 9799055
[TBL] [Abstract][Full Text] [Related]
16. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions.
Chang SL; Banga AK
J Pharm Pharmacol; 1998 Jun; 50(6):635-40. PubMed ID: 9680073
[TBL] [Abstract][Full Text] [Related]
17. A transdermal delivery system for glipizide.
Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin.
Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI
Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932
[TBL] [Abstract][Full Text] [Related]
19. [In vitro transdermal permeation of main compositions in Baimai Ointment].
Liang J; Wu HC; DU SY; Liu CF; Zhong LY; Zhang Q; Tian WW; Liu DH
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2486-2492. PubMed ID: 31359715
[TBL] [Abstract][Full Text] [Related]
20. Application of lipid microspheres containing prostaglandin E1 ointment to peripheral ischemic ulcers.
Sakakibara Y; Jikuya T; Mitsui T
Dermatology; 1997; 195(3):253-7. PubMed ID: 9407173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
